| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 104,291 | $12,053,953 | $115.58 | 02 Mar 2026 | Direct |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 11,845 | $1,312,781 | $110.83 | 27 Feb 2026 | Profit Sharing Trust |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Option (right to buy) | 57,512 | 24 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27 Feb 2026 | 2 | -$609,134 | 4 | EXECUTIVE VICE PRESIDENT | 03 Mar 2026, 20:00 |
| ABT | ABBOTT LABORATORIES | 24 Feb 2026 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 26 Feb 2026, 18:43 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2025 | 2 | -$869,893 | 4 | EXECUTIVE VICE PRESIDENT | 04 Mar 2025, 19:44 |
| ABT | ABBOTT LABORATORIES | 25 Feb 2025 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 27 Feb 2025, 18:26 |
| ABT | ABBOTT LABORATORIES | 29 Feb 2024 | 2 | -$783,839 | 4 | EXECUTIVE VICE PRESIDENT | 04 Mar 2024, 19:09 |
| ABT | ABBOTT LABORATORIES | 21 Feb 2024 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2024, 17:38 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2023 | 2 | -$663,489 | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2023, 18:45 |
| ABT | ABBOTT LABORATORIES | 17 Feb 2023 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 22 Feb 2023, 18:14 |
| ABT | ABBOTT LABORATORIES | 01 Aug 2022 | 1 | -$135,506 | 4 | EXECUTIVE VICE PRESIDENT | 03 Aug 2022, 12:27 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2022 | 1 | -$503,350 | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2022, 18:52 |
| ABT | ABBOTT LABORATORIES | 18 Feb 2022 | 4 | -$140,337 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2022, 19:23 |
| ABT | ABBOTT LABORATORIES | 01 Aug 2021 | 1 | -$150,620 | 4 | EXECUTIVE VICE PRESIDENT | 03 Aug 2021, 17:40 |